Citation:KConFab Investigators, Willems AJ, Dawson SJ, Samaratunga H, De Luca A, Antill YC, et al 2008
From National Cancer Control Policy
kConFab Investigators, Willems AJ, Dawson SJ, Samaratunga H, De Luca A, Antill YC, et al. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clin Cancer Res 2008 May 15;14(10):2953-61 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18445692.
Critical appraisals